Director, Strategic Pricing

As the Director of Strategic Pricing at Biogen, you will be instrumental in leading the Rare Disease Market Access Strategy team. Your primary focus will be on developing and executing market access strategies for SMA and ALS, ensuring alignment with the Rare Disease Franchise. Reporting to the Head of Rare Disease Access Strategy within the US Market Access & Reimbursement, your role is pivotal in optimizing patient access through strategic pricing and innovative contracting approaches. This position holds a significant impact on the business by driving payer messaging, coordinating across various functions, and delivering value propositions that resonate with key customer segments. In this role, you will be at the forefront of shaping access strategy, ensuring seamless coordination and alignment across all Market Access & Reimbursement functions.

What You’ll Do:

• Develop and execute comprehensive market access strategies to support the SMA and ALS brands across commercial and government payer segments.
• Lead cross-functional planning and execution across all MA&R functions to ensure alignment with approved strategies.
• Ensure coordination and alignment with the Rare Disease Franchise on overall strategy and messaging.
• Deliver impactful value propositions and promotional materials tailored to key customer segments.
• Champion pull-through activities to ensure access optimization.
• Partner with Medical, HEOR, Global V&A to support evidence generation for access strategy.
• Define and drive the contracting strategy in collaboration with Brand, legal, and finance teams.
• Develop pricing and innovative contracting strategies, including value-based contracts.
• Work with cross-functional teams to model scenario-based business cases for contracting recommendations.
• Research and analyze market landscape data/trends to develop customized solutions for patient access.
• Support development of Free Drug and co-pay support strategies.
• Execute and support training of MA&R RADs and NADs in alignment with approved strategies.
• Lead initiatives to evaluate MA&R performance in support of the Rare Disease Franchise.
• Lead and support multiple cross-functional teams in various projects as a market access expert.
• Support pipeline activities, including Biogen’s pipeline assets for the SMA and ALS populations.

Who You Are: You are a proactive team leader with strong communication and analytic skills, deeply rooted in the complexities of the US healthcare system. Your expertise in driving strategic initiatives and collaborating across functions sets you apart. You thrive in dynamic environments and possess the ability to translate complex data into actionable strategies, making you a vital asset to the team.

Required Skills:

• Bachelor's degree required, MBA preferred.
• 10+ years of experience in U.S. market access, payer marketing, pricing, or related fields within the pharmaceutical or biotech industry.
• Ability to work cross-functionally to develop payer messaging and contracting strategy.
• Knowledge of standard payer research methodologies, financial analyses, and gross-to-net dynamics.
• Excellent analytical, strategic thinking, and critical thinking skills.
• Strong interpersonal and communication skills.

#LI-NP1

Job Level: Management

Additional Information

The base compensation range for this role is: $200,000.00-$275,000.00

Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.

Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.

In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being ; including, but not limited to:

• Medical, Dental, Vision, & Life insurances
• Fitness & Wellness programs including a fitness reimbursement
• Short- and Long-Term Disability insurance
• A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
• Up to 12 company paid holidays + 3 paid days off for Personal Significance
• 80 hours of sick time per calendar year
• Paid Maternity and Parental Leave benefit
• 401(k) program participation with company matched contributions
• Employee stock purchase plan
• Tuition reimbursement of up to $10,000 per calendar year
• Employee Resource Groups participation

Why Biogen?

We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.

At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about Biogen.

All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.